Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study have?
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study has 107 citations in the OpenAlex counts ScholarIQ stores.
When was Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study published?
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study has 2013 year in the ScholarIQ index.
What is the open-access status of Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study?
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study has closed oa status in the ScholarIQ index.
What is the DOI of Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study?
The DOI for Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study is on the source record.
What is the PMID of Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study?
The PMID for Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study is on the source record.
What is the OpenAlex record for Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study?
The OpenAlex for Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study is on the source record.